Fig. 2From: Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic reviewForest plots presenting pooled ORR risk ratio analysis in advanced lung cancer and ORR risk ratio analysis for the cohort of immunotherapy alone and immunotherapy combined with other therapiesBack to article page